HomeCompareCAECX vs JNJ

CAECX vs JNJ: Dividend Comparison 2026

CAECX yields 8.77% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CAECX wins by $15.7K in total portfolio value
10 years
CAECX
CAECX
● Live price
8.77%
Share price
$22.80
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$35.7K
Annual income
$1,525.90
Full CAECX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CAECX vs JNJ

📍 CAECX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCAECXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CAECX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CAECX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CAECX
Annual income on $10K today (after 15% tax)
$745.61/yr
After 10yr DRIP, annual income (after tax)
$1,297.02/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, CAECX beats the other by $593.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CAECX + JNJ for your $10,000?

CAECX: 50%JNJ: 50%
100% JNJ50/50100% CAECX
Portfolio after 10yr
$27.9K
Annual income
$1,176.84/yr
Blended yield
4.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CAECX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CAECX buys
0
JNJ buys
0
No recent congressional trades found for CAECX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCAECXJNJ
Forward yield8.77%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$35.7K$20.0K
Annual income after 10y$1,525.90$827.78
Total dividends collected$12.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CAECX vs JNJ ($10,000, DRIP)

YearCAECX PortfolioCAECX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,577$877.19$10,676$355.77+$901.00CAECX
2$13,337$949.11$11,407$389.39+$1.9KCAECX
3$15,292$1,021.82$12,198$426.53+$3.1KCAECX
4$17,458$1,094.99$13,056$467.62+$4.4KCAECX
5$19,848$1,168.27$13,987$513.12+$5.9KCAECX
6$22,479$1,241.34$14,998$563.56+$7.5KCAECX
7$25,366$1,313.89$16,098$619.52+$9.3KCAECX
8$28,527$1,385.67$17,295$681.69+$11.2KCAECX
9$31,980$1,456.41$18,599$750.82+$13.4KCAECX
10$35,745$1,525.90$20,022$827.78+$15.7KCAECX

CAECX vs JNJ: Complete Analysis 2026

CAECXStock

The fund normally invests at least 80% of its net assets (plus any borrowing for investment purposes) in European companies. It invests at least 70% of its total assets in companies in Western European countries, but also may invest up to 30% of its total assets in companies in emerging Central and Eastern European countries.

Full CAECX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CAECX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CAECX vs SCHDCAECX vs JEPICAECX vs OCAECX vs KOCAECX vs MAINCAECX vs ABBVCAECX vs MRKCAECX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.